Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

The FDA approval marks the first approval of a type of pre-exposure prophylaxis that would only require 2 treatments per year ...

Although HIV may affect sperm quality and male fertility by numerous mechanisms the face of HIV care has dramatically changed ...

A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...

Amy Grant joined artists Matt Maher, Brandon Health, Charlie Peacock and Steve Taylor at a performance at Otter Creek Church ...

Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.

Lenacapavir, the world's first twice-yearly HIV prevention shot, gets US FDA nod-offering a discreet, long-acting solution ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

The University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC) is intensifying its efforts to find a cure for HIV, as ...

Discover the inspiring story of Dr Suniti Solomon and Dr Sellappan Nirmala, who pioneered HIV prevention in India, facing ...

THE University of Zimbabwe Clinical Trials Research Centre (UZ-CTRC) is continuing research into finding a cure for HIV as the country seeks to ensure the chronic disease ceases to be a public health ...

Understanding trade-offs can help countries better prepare for future health emergencies and treat chronic conditions ...